PATENT CLAIM ANALYSIS

Application Number: 16124057
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-03
Patent Classification: ["546", "200000"]

Abstract:
Provided herein is a crystalline 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione hemihydrate. Pharmaceutical compositions comprising the crystalline 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione hemihydrate are also disclosed.

Claim (Index 13):
The hemihydrate of  claim 1 , which is substantially chemically pure.

Metadata:
- Claim Count in Document: 32.0
- Percentile: 97.0
- Lexical Diversity: 1.42105
- Patent Class: 546.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15849324', '15849442', '16124013', '16124066', '15849285']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8579938078463891
- 35 USC 102 Novelty (BERT): 0.5996808601277478
- Combined Prediction Score: 0.832162513074525
- Mean Citation Score: 600.383446
- Max Citation Score: 647.1748
- Similarity Product: 444.7746347652197

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test